EHA news
EHA and the European Cancer Patient Coalition co-hosted a meeting at the European Parliament in Brussels on August 30-31, 2011. The two-day conference was attended by doctors, researchers, parliamentarians, patient advocates and Commission officials. The full report of this meeting is available here.
On November 30, 2011, the European Commission presented its proposal for Horizon 2020, the financial instrument for research and innovation funding from 2014-2020. The €80 billion Horizon 2020 will replace the current (€51 billion) Framework Programme 7 (FP7).
A very successful 5th 'Focus in Pediatric Haematology-Oncology' course was held from October 23-26 in Sorrento in a small, friendly hotel with excellent facilities on the edge of the beautiful southern end of the Bay of Naples.
The current revision of two European Directives that are crucial to successful research into blood-related diseases must ensure the safety of patients and enhance their access to vitally-important treatment.
Research into blood-related diseases saves and improves the lives of millions of EU citizens each year, but lack of awareness of this fact means that too often, funding does not feed directly enough into advancing the treatment of patients.
On the 30th and 31st of August a conference will be hosted in the European Parliament that will demonstrate the leading role hematology will have in securing the future knowledge economy envisaged in the Europe 2020 Strategy.
Dr A van Hylckama Vlieg was recently awarded the very first Joint Fellowships of the European Hematology Association (EHA)-International Society on Thrombosis and Haemostasis (ISTH) at the16th Congress of EHA in London, UK.
At the 16th Congress of EHA in London the EHA Jean Bernard Lifetime Achievement Award will be handed to Professor Bob Löwenberg and the EHA José Carreras Award to Professor Douglas Higgs.